Updated July 24 at 5:26am
Biotechnology
42 results total, viewing 1 - 10
A Chinese drug manufacturer is investing $42 million in Nabsys, which recently completed a financial restructuring that allowed it to reopen in March after being out of business for nearly seven months. more
IlluminOss Medical Inc. said Monday that it has completed enrollment in its first U.S. clinical trial toward U.S. Food and Drug Administration approval of its IlluminOss System, a minimally invasive system to repair bone fractures. more
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
Ximedica, a medical-technology-development company, has acquired Accel Biotech based in Los Gatos, Calif. more
The University of Massachusetts was granted 62 utility patents in 2015, putting the school at No. 30 on a list of the Top 100 worldwide universities that were granted U.S. patents. more
(Updated, 6:15 p.m.) Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC. more
Alexion Pharmaceuticals Inc. is planning a $200 million phased expansion of its manufacturing plant here, to facilitate production of its drug, Soliris, and other products. more
U.S. stocks rose for the first time since Britain voted to leave the European Union, rebounding amid optimism that policymakers are committed to limit the fallout from the U.K.’s exit. more
More than $480,000 has been awarded by the Rhode Island Foundation in seed funding for 20 medical research projects. more
Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its primary goal in a final-stage trial. more
1 | 2 | 3 | 4 | 5 Next »